Jump Financial’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.06M Buy
155,776
+124,789
+403% +$5.75M 0.13% 195
2025
Q4
$1.39M Buy
30,987
+24,487
+377% +$1.03M 0.02% 839
2025
Q3
$261K Sell
6,500
-10,491
-62% -$369K ﹤0.01% 1539
2025
Q2
$532K Buy
+16,991
New +$554K 0.01% 1207
2024
Q4
Sell
-45,000
Closed -$1.77M 2066
2024
Q3
$1.77M Sell
45,000
-3,166
-7% -$128K 0.04% 571
2024
Q2
$1.88M Buy
48,166
+2,087
+5% +$83.4K 0.04% 580
2024
Q1
$1.98M Buy
46,079
+22,079
+92% +$1.02M 0.05% 450
2023
Q4
$1.11M Buy
+24,000
New +$848K 0.04% 664
2023
Q1
Sell
-7,725
Closed -$305K 2117
2022
Q4
$305K Sell
7,725
-45,575
-86% -$1.66M 0.02% 1039
2022
Q3
$1.92M Buy
+53,300
New +$1.92M 0.07% 394
2022
Q2
Sell
-30,101
Closed -$920K 2068
2022
Q1
$920K Sell
30,101
-1,199
-4% -$35.9K 0.04% 555
2021
Q4
$978K Buy
+31,300
New +$935K 0.06% 394

Other funds holding XENE